Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks

NCT02240784 is registered in ClinicalTrials.gov with Alnylam Pharmaceuticals as lead sponsor.

NCT NCT02240784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02240784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks
Lead sponsor
Alnylam Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
April 26, 2021
Enrollment
136 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

acute hepatic porphyria